Cargando…

Differences in clinical and imaging characteristics between p16-positive non-smokers and p16-positive smokers or p16-negative patients in oropharyngeal carcinoma

The eighth edition of the TNM classifies oropharyngeal squamous cell carcinomas (OSCCs) depending on p16 status. Some imaging features are reportedly associated more frequently with p16-positive (P16+) OSCC than p16-negative (p16−) OSCC. However, classical risk factors such as tobacco use were not s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trinh, Jean-Michel, Thomas, Jacques, Salleron, Julia, Henrot, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870833/ https://www.ncbi.nlm.nih.gov/pubmed/33558647 http://dx.doi.org/10.1038/s41598-021-82999-3

Ejemplares similares

Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
por: Adrian, Gabriel, et al.
Publicado: (2022)

Induction Chemotherapy for p16 Positive Oropharyngeal Squamous Cell Carcinoma
por: Saito, Yuki, et al.
Publicado: (2016)

Genomic Copy Number Variations Characterize the Prognosis of Both P16-Positive and P16-Negative Oropharyngeal Squamous Cell Carcinoma After Curative Resection
por: Rhie, Arang, et al.
Publicado: (2015)

The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications
por: Hussain, Timon, et al.
Publicado: (2022)

Treatment failure patterns are similar between p16− and p16+ oropharyngeal squamous cell carcinomas
por: Hamill, Chelsea S., et al.
Publicado: (2022)

Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation
por: Gorphe, Philippe, et al.
Publicado: (2017)

Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma
por: Clark, Jessica, et al.
Publicado: (2015)

Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer
por: Wang, Zhongqiu, et al.
Publicado: (2012)

Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy
por: Inukai, Daisuke, et al.
Publicado: (2020)

Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Margin Sampling and Survival Outcomes in Oral Cavity and p16-Positive Oropharyngeal Squamous Cell Carcinoma
por: MacKay, Colin, et al.
Publicado: (2022)

Prognostic Value of Pathologically Positive Nodal Number in p16-Negative Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma with pN3b Status
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Association of p16 as Prognostic Factors for Oropharyngeal Cancer: Evaluation of p16 in 1470 Patients for a 16 Year Study in Northeast China
por: Meng, Hong-xue, et al.
Publicado: (2018)

Clinical impact of p16 positivity in nasopharyngeal carcinoma
por: Shimizu, Yuri, et al.
Publicado: (2022)

Correction to: Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Frequent Epigenetic Silencing of the p16 Gene in Non‐small Cell Lung Cancers of Tobacco Smokers
por: Yanagawa, Naoki, et al.
Publicado: (2002)

Evaluation of p16 expression in oral and oropharyngeal squamous cell carcinoma
por: Saxena, Pallavi, et al.
Publicado: (2022)

Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma
por: Yang, Yifan, et al.
Publicado: (2022)

Interferon Inducible IFI16 Expression in p16 Positive Squamous Cell Carcinoma of the Oropharynx
por: Yamauchi, Moriyasu, et al.
Publicado: (2013)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
por: Chang, Pei-Hung, et al.
Publicado: (2021)

HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
por: Wasserman, Jason K., et al.
Publicado: (2017)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan
por: Adilbay, Dauren, et al.
Publicado: (2018)

Meiotic and pedigree segregation analyses in carriers of t(4;8)(p16;p23.1) differing in localization of breakpoint positions at 4p subband 4p16.3 and 4p16.1
por: Midro, Alina T., et al.
Publicado: (2015)

Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patients
por: Verma, Vivek, et al.
Publicado: (2015)

Correction to: HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
por: Wasserman, Jason K., et al.
Publicado: (2018)

Prediction of Occult Contralateral Nodal Metastasis in Surgical Treated p16 Negative Oropharyngeal Squamous Cell Carcinoma
por: Huang, Hui-Shan, et al.
Publicado: (2022)

Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma
por: Sandström, Karl, et al.
Publicado: (2023)

Human Papillomavirus Detection in Oropharyngeal Squamous Cell Carcinoma Using p16 Immunohistochemistry
por: Sabu, Annetmary, et al.
Publicado: (2019)

Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma
por: de C. Ferreira, Chrystiano, et al.
Publicado: (2021)

Trends in Swallowing Outcomes Following Deintensified Treatment in Selected p16+ Oropharyngeal Carcinoma
por: Lee, Esther, et al.
Publicado: (2023)

Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer
por: Chi, Jeffrey, et al.
Publicado: (2020)

Cutaneous HPV16 and p16 Positive Basaloid Squamous Cell Carcinoma with Brain Metastasis: A Case Report
por: Vu, Trang T, et al.
Publicado: (2020)

Viral Integration Analysis Reveals Likely Common Clonal Origin of Bilateral HPV16-Positive, p16-Positive Tonsil Tumors
por: Pinatti, Lisa M., et al.
Publicado: (2020)

Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma
por: Kawakami, Hisato, et al.
Publicado: (2013)

Synchronous p16(+) nasopharyngeal and oropharyngeal squamous cell carcinoma: a case report and review
por: Ali, Muhammad, et al.
Publicado: (2021)

Increased PD-L1 and p16 expression are common in oropharyngeal squamous cell carcinoma
por: Shestakova, Anna, et al.
Publicado: (2021)

Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx
por: Junor, E, et al.
Publicado: (2012)

Fluorodeoxyglucose positron emission tomography/computed tomography identifying pericardial metastasis from early‐stage p16‐positive oropharyngeal cancer
por: Shim, Hye‐kyung, et al.
Publicado: (2020)

Usefulness of circulating tumor DNA by targeting human papilloma virus-derived sequences as a biomarker in p16-positive oropharyngeal cancer
por: Akashi, Ken, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2pi27foc5j3pegt3sqk1tke1qu